Proton Therapy Systems Market is there to witness a placid CAGR of 15.2% between 2017 -2024, reaching US$ 3,000 Mn. Telehealth has turned out to be a boon be it with remote monitoring or treating several patients at a distance simultaneously. The time as well stresses on the part of patients and physicians gets saved this way. Virtual follow-up also opens doors for multitasking by the healthcare personnel. This is the present and also would be the future of the healthcare vertical.
Growing prevalence of cancer has prompted medical organizations towards development and adoption of advanced treatment procedures, such as proton radiotherapy. The effectiveness of proton therapy continues to gain trust of cancer patients across the globe. The procedure is known for successfully destructing tumor cells by damaging their DNA through a targeted deposition of high-energy radiation dosage onto the tumor.
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12358
Furthermore, doctors treating cancer patients are also benefiting from the feasibility of proton therapy as it can be used in conjunction with other treatments. Factors as such continue to promote the adoption of proton therapy for curing cancerous abnormalities. Persistence Market Research projects that by the end of 2024, the global market for proton therapy will bring in more than US$ 2,926.7 Mn in revenues.
Company Profiles
Hitachi Ltd.
Ion Beam Applications SA
Mevion Medical Systems
Mitsubishi Electric Corporation
ProNova Solutions, LLC
ProTom International
Sumitomo Heavy Industries Ltd.
Varian Medical Systems
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/12358
In the report, titled Proton Therapy Market: Global Industry Analysis and Forecast, 2016-2024, the global market for proton therapy is presently valued at closed to US$ 945 Mn and is projected to soar at a healthy CAGR of 15.2%. The report estimates that governments from all corners of the globe will continue to shore up their healthcare expenditure on cancer care facilities, which will incidentally boost the revenues in global proton therapy market. Additional benefits of availing proton therapy, compared to chemotherapy or radiation therapy, will also instrument a steadfast revenue growth for the market.
Based on a regional analysis compiled in the report, North America is projected to account for a little less than one-third share of global proton therapy revenues throughout the forecast period. However, Europes proton therapy market will dominate with close to 38% share and showcase revenue growth at 15.7% CAGR.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/12358
Key highlights of the research report on global proton therapy market follow:
The market is likely to benefit from companies manufacturing compact set up used in proton beam therapy, which help in saving production costs without impairing product efficacy
Based on such set ups, multiple-room proton therapy will gain traction by accounting for more than three-fourth of global revenues towards the end of forecast period
Among multiple cancer indications, the adoption of proton therapy will be relatively higher for treatment of lung cancer, gastro-intestinal cancer, pediatric cancer, head & neck cancer
Flexible payment options are also boosting the supply of proton therapy devices, while affordability of such devices continues to be a major challenge
The report also predicts that the demand for proton therapy will be impacted by the therapys side-effects which include fatigue, skin irritation, swelling and skin blistering
Nonetheless, the market will witness opportunistic growth in terms of rising preference to non-invasive treatment of cancerous tumors
You Can Read Also-
Global Compression Socks Market –
Persistence Market Research has projected around 5% CAGR for compression sock sales during 2021-2031. Current market volume is estimated to be around 630 Mn, and is set to top US$ 1 Bn by 2031.
Active Pharmaceutical Ingredient Market –
Persistence Market Research has projected over 4% CAGR for active pharmaceutical ingredient sales during 2021-2031.
Demand for hemodialysis devices is expected to increase 3% to around 65,181,120 units by 2031
Plant Disease Diagnostics Market –
The global plant disease diagnostics market was valued at US$ 88.8 Mn in 2020, and is expected to register a CAGR of 4.2% over the forecast period (2021-2031).
About us:
PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.
Contact us:
Persistence Market Research
Address 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. +1-646-568-7751
USA-Canada Toll-free +1 800-961-0353
Sales sales@persistencemarketresearch.com
